Impact of maternal dexamethasone on coronary PGE2 production and prostaglandin-dependent coronary reactivity

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 303, Issue 5, 2012, Pages

  Roghair, Robert D ^a   Volk, Kenneth A ^a   Lamb, Fred S ^a   Segar, Jeffrey L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Cyclooxygenase; Fetal programming; Prostaglandin; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN II; ARACHIDONIC ACID; DEXAMETHASONE; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY MUSCLE; ARTERY TONE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; DRUG ANTAGONISM; EWE; FEMALE; ISOTOPE LABELING; LAMB; MYOGRAPHY; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; PROSTAGLANDIN SYNTHESIS;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; CORONARY VESSELS; CYCLOOXYGENASE INHIBITORS; DEXAMETHASONE; DINOPROSTONE; FEMALE; GLUCOCORTICOIDS; INDOMETHACIN; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSTAGLANDINS; SHEEP; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 84865712156     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00658.2011     Document Type: Article

References (44)

1. Barker DJP. Mothers, Babies and Health in Later Life. Edinburgh, UK: Churchill Livingstone, 1998.
2. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CRW. Glucocortoid exposure in utero: new model for adult hypertension. Lancet 341: 339-341, 1993.
3. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ, for The Study Group VIGOR. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 343: 1520-1528, 2000.
4. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA. Adenomatous polyp prevention on Vioxx (APPROVe) trial investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352: 1092-1102, 2005.
5. Brown RW, Chapman KE, Kotelevtsev Y, Yau JL, Lindsay RS, Brett L, Leckie C, Murad P, Lyons V, Mullins JJ, Edwards CR, Seckl JR. Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2. Biochem J 313: 1007-1017, 1996.
6. Burleigh ME, Babaev VR, Oates JA, Harris RC, Guatam S, Riendeau D, Marnett LJ, Morrow JD, Fazio S, Linton MF. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 105: 1816-1823, 2002.
7. Cheng HF, Wang JL, Zhang MZ, McKanna JA, Harris RC. Role of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride. J Clin Invest 106: 681-688, 2000.
8. Cipollone F, Rocca B, Patrono C. Cyclooxygensase-2 expression and inhibition in atherothrombosis. Arterioscler Thromb Vasc Biol 24: 246-255, 2004.
9. Cueille C, Frayon S, de Vernejoul MC, Garel JM. Dexamethasone decreases phospholipase C beta1 isozyme expression in human vascular smooth muscle cells. J Steroid Biochem Mol Biol 86: 173-178, 2003.
10. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL, Stampfer MJ. Prevention of cardiovascular disease: birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation 94: 3246-3250, 1996.
11. Deitemeyer D, Yunker RL, Ashraf M, Subbiah MT. Effect of glucocorticoid administration early in life on aortic prostaglandin synthesis and morphology in atherosclerosis-susceptible pigeons. Exp Clin Endocrinol 85:147-154, 1985.
12. Dodic M, May CN, Wintour EM, Coghlan JP. An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin Sci 94: 149-155, 1998.
13. Drake AJ, Walker BR, Seckl JR. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. Am J Physiol Regul Integr Comp Physiol 288: R34-R38, 2005.
14. Dzau VJ. Cell biology and genetics of angiotensin in cardiovascular disease. J Hypertens 12: S3-S10, 1994.
15. Freeman EJ, Ruehr ML, Dorman RV. ANG II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells. Am J Physiol Cell Physiol 274: C282-C288, 1998.
16. Handa M, Kondo K, Suzuki H, Saruta T. Dexamethasone hypertension in rats: role of prostaglandins and pressor sensitivity to norepinephrine. Hypertension 6:236-241, 1984.
17. Kubuju DA, Herschman HR. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J Biol Chem 267: 7991-7994, 1992.
18. Langley-Evans SC, Phillips GJ, Gardner DS, Jackson AA. Role of glucocorticoids in programming of maternal diet-induced hypertension in the rat. J Nutr Biochem 7: 173-178, 1996.
19. Leon DA, Lithell HO, Vâgerö D, Koupilová I, Mohsen R, Berglund L, Lithell UB, McKeigue PM. Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15,000 Swedish men and women born 1915-1929. Br Med J 317: 241-245, 1998.
20. Liggins GC. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 45:515-523, 1969.
21. Lindsay RS, Lindsay RM, Edwards CRW, Seckl JR. Inhibition of 11α-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension 27: 1200-1204, 1996.
22. Maier JA, Barenghi L, Bradamante S, Pagani F. Modulators of oxidized LDL-induced hyperadhesiveness in human endothelial cells. Biochem Biophys Res Commun 204: 673-677, 1994.
23. Masferrer JL, Seibert K, Zweifel BS, Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 89: 3917-3921, 1992.
24. McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA, FitzGerald GA. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 96: 272-277, 1999.
25. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonté B, Szyf M, Turecki G, Meaney MJ. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12: 342-348, 2009.
26. Mitchell J, Belvisi M, Akarasereenont P, Robbins RA, Kwon OJ, Croxtall J, Barnes PJ, Vane JR. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by Dexamethasone. Br J Pharmacol 113: 1008-1014, 1994.
27. Murakami M, Naraba H, Tanioka T, Semmyo N, Nakatani Y, Kojima F, Ikeda T, Fueki M, Ueno A, Oh S, Kudo I. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 275: 32783-32792, 2000.
28. Murphy BE, Clark SJ, Donald IR, Pinsky M, Vedady D. Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. Am J Obstet Gynecol 118: 538-541, 1974.
29. Newton R, Seybold J, Kuitert LME, Bergmann M, Barnes PJ. Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J Biol Chem 273: 32312-32321, 1998.
30. Olesen M, Kwong E, Maztli A, Kontny F, Seljeflot I, Arnesen H, Lyngdorf L, Falk E. No effect of cyclooxygenase inhibition on plaque size in atherosclerosis-prone mice. Scand Cardiovasc J 36: 362-367, 2002.
31. Oltman CL, Kane NL, Miller FJ Jr, Spector AA, Weintraub NL, Dellsperger KC. Reactive oxygen species mediate arachidonic acidinduced dilation in porcine coronary microvessels. Am J Physiol Heart Circ Physiol 285: H2309-H2315, 2003.
32. Pratico D, Tillmann C, Zhang ZB, Li H, FitzGerald GA. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. Proc Natl Acad Sci USA 98: 3358-3363, 2001.
33. Rich-Edwards JW, Stampfer MJ, Manson JE, Rosner B, Hankinson SE, Colditz GA, Willett WC, Hennekens CH. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. Br Med J 315: 396-400, 1997.
34. Roghair RD, Lamb FS, Miller FJ Jr, Scholz TD, Segar JL. Early gestation dexamethasone programs enhanced postnatal ovine coronary artery vascular reactivity. Am J Physiol Regul Integr Comp Physiol 288: R46-R53, 2005.
35. Roghair RD, Miller FJ Jr, Scholz TD, Lamb FS, Segar JL. Coronary constriction to angiotensin II is enhanced by endothelial superoxide production in sheep programmed by dexamethasone. Pediatr Res 63: 370-374, 2008.
36. Roghair RD, Segar JL, Sharma RV, Zimmerman MC, Jagadeesha DK, Segar EM, Scholz TD, Lamb FS. Newborn lamb coronary artery reactivity is programmed by early gestation dexamethasone before the onset of systemic hypertension. Am J Physiol Regul Integr Comp Physiol 289: R1169-R1176, 2005.
37. Rott D, Zhu J, Burnett MS, Zhou YF, Zalles-Ganley A, Ogunmakinwa J, Epstein SE. Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomega-lovirus replication in apolipoprotein-E knockout mice. J Am Coll Cardiol 41: 1812-1819, 2003.
38. Schonbeck U, Sukhova GK, Graber P, Coulter S, Libby P. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol 155: 1281-1291, 1999.
39. Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, Avorn J. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation 109: 2068-2073, 2004.
40. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105: 1429-1435, 2002.
41. Thengchaisri N, Kuo L. Hydrogen peroxide induces endothelium-dependent and -independent coronary arteriolar dilation: role of cyclooxygenase and potassium channels. Am J Physiol Heart Circ Physiol 285: H2255-H2263, 2003.
42. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, Dymov S, Szyf M, Meaney MJ. Epigenetic programming by maternal behavior. Nat Neurosci 7: 847-854, 2004.
43. Yamada M, Niki H, Yamashita M, Mue S, Ohuchi K. Prostaglandin E2 production dependent upon cyclooxygenase-1 and cyclooxygenase-2 and its contradictory modulation by auranofin in rat peritoneal macrophages. J Pharmacol Exp Ther 281: 1005-1012, 1997.
44. Yang T, Park JM, Arend L, Huang Y, Topaloglu R, Pasumarthy A, Praetorius H, Spring K, Briggs JP, Schnermann J. Low chloride stimulation of prostaglandin E2 release and cyclooxygenase-2 expression in a mouse macula densa cell line. J Biol Chem 275: 37922-37929, 2000.